How NLP Helps Life Sciences Companies Unlock Insights from Drug Labels
PM360
NOVEMBER 29, 2022
When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. Understanding patient sub-group exceptions for competitive or for label development purposes.
Let's personalize your content